Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi adds a $120M computational drug design deal with Schrödinger
Fierce Biotech
Thu, 04/2/15 - 11:05 am
Tags:
Sanofi, Schrödinger, R&D
Confirmed: Sanofi's Toujeo launches in US Monday, setting up diabetes race
BioPharma Dive
Mon, 03/30/15 - 10:49 am
Tags:
Sanofi, Toujeo, diabetes, drug launches
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Tags:
Opdivo, Praluent, LCZ696, lumacaftor, Viekira Pak, evolocumab, Gardasil 9, brexpiprazole, Toujeo, Cosentyx, Bristol-Myers Squibb, Regeneron, Sanofi, Novartis, Pfizer, AbbVie, Amge, Astellas, Merck, Otsuka, Lundbeck, Vertex Pharmaceuticals
Novo Nordisk's Tresiba news a black cloud for Sanofi's new CEO
Fierce Pharma
Fri, 03/27/15 - 09:44 pm
Tags:
Novo Nordisk, Tresiba, Sanofi, Lantus, Olivier Brandicourt
Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source
Yahoo/Reuters
Fri, 03/27/15 - 12:00 pm
Tags:
Sanofi, Toujeo, diabetes, drug launches
Opdivo, Praluent and LCZ-696 top a launch crop poised for $27B in sales
Fierce Pharma Marketing
Wed, 03/25/15 - 03:13 pm
Tags:
drug launches, Opdivo, Bristol-Myers Squibb, Praluent, Sanofi, Regeneron, LCZ696, Novartis
Why It Makes Sense For Sanofi To Acquire Zoetis
Seeking Alpha
Wed, 03/25/15 - 10:34 am
Tags:
Sanofi, Zoetis, M&A, animal health
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
Tags:
biotech, Opdivo, Praluent, LCZ696, Ibrance, Viekira Pak, evolocumab, Gardasil 9, Bristol-Myers Squibb, Regeneron, Sanofi, Novartis, Pfizer, Vertex Pharmaceuticals, Merck, Amgen, AbbVie, Astellas
Bristol, Sanofi and Novartis drugs to shine among 2015 launches
Yahoo/Reuters
Mon, 03/23/15 - 09:21 am
Tags:
drug launches, Sanofi, Novartis, Bristol-Myers Squibb. LCZ-696, Opdivo, Praluent
New Cholesterol Meds May Lower Heart Risks, but Will They Break the Bank?
WSJ Pharmalot
Fri, 03/20/15 - 10:58 am
Tags:
PCSK9 inhibitors, Sanofi, Regeneron, Amgen
Sanofi's diabetes franchise one step closer to U.S. Lyxumia launch
Fierce Pharma
Thu, 03/19/15 - 11:43 am
Tags:
Sanofi, diabetes, Lyxumia
Sanofi test shows lixisenatide doesn't increase cardiovascular risk
Yahoo/Reuters
Thu, 03/19/15 - 11:07 am
Tags:
Sanofi, lixisenatide
Sanofi R&D head bemoans divergence in global drug regulation
Yahoo/Reuters
Wed, 03/18/15 - 08:04 pm
Tags:
Sanofi, R&D, regulatory
Top 15 pharma companies by 2014 revenue
Fierce Pharma
Wed, 03/18/15 - 11:04 am
Tags:
JNJ, Novartis, Roche, Pfizer, Sanofi, Merck, GSK, AstraZeneca, Bayer
A Look At Afrezza Prescriptions Through Week 6 And Predictions Through Week 10
Seeking Alpha
Mon, 03/16/15 - 10:53 am
Tags:
Afrezza, MannKind, Sanofi, insulin, diabetes
R&D exec Tal Zaks leaps from flagging Sanofi to fast-growing Moderna
Fierce Biotech
Mon, 03/16/15 - 10:44 am
Tags:
R&D, Sanofi, Tal Zaks, Moderna Therapeutics
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
Tags:
PCSK9 inhibitors, alirocumab, evolocumab, Amgen, Sanofi, Regeneron
Sanofi backs pitch to turn Marseille into an immunotherapy R&D hub
Fierce Biotech
Wed, 03/11/15 - 10:15 am
Tags:
Sanofi, R&D, France
If You 'Want To Make A Good Drug Great' Cost Must Be Factored In
Forbes
Tue, 03/3/15 - 09:54 am
Tags:
drug pricing, Afrezza, MannKind, Sanofi, inhaled insulin
MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
TheStreet.com
Mon, 03/2/15 - 09:11 am
Tags:
MannKind, Afrezza, insulin, diabetes, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.